Sign Out
UserName
Profession Email
Profession Email
|
Special Precautions
Patients with risk factors of cystoid macular oedema, history of intraocular inflammation (e.g. uveitis, iritis). Aphakic, and pseudophakic patients with torn posterior lens capsule. Children. Pregnancy and lactation. Patient Counselling Remove contact lenses prior to ophth administration and reinsert after 15 minutes. This drug may cause transient effects on vision, if affected, do not drive or operate machinery.
|
|
Adverse Reactions
Significant: Iris hyperpigmentation, macular oedema, bacterial keratitis, changes in length, thickness, pigmentation or number of eyelashes.
Eye disorders: Ocular hyperaemia, cataract, conjunctivitis, decreased visual acuity, blurred vision, blepharitis, corneal staining, ocular inflammation, photophobia, crusting of eyelid margin, foreign body sensation in eyes, deepening of eyelid sulcus, eye tearing, pain in the eye, dry eye, ocular pruritus, ocular discomfort.
|
|
CIMS Class
|
|
ATC Classification
S01EE04 - travoprost ; Belongs to the class of prostaglandin analogues. Used in the treatment of glaucoma.
|
